TX Houston의 두경부암 임상 시험
두경부암 관련 연구 30개가 Houston 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
연구 대상자를 모집 중이신가요? 이 페이지 상단에 노출하세요 — 30일 동안 $99 →
Phase I Study of Preconditioning Radiation Therapy With IL-15 Transduced TGFBR2 KO CAR.TROP2-engineered Cord Blood-derived NK Cells in Patients With Advanced Head and Neck Cancer (RADIANCE-NK)
피험자 모집 중1상
- The University of Texas M. D. Anderson Cancer Center, Houston
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
피험자 모집 중1/2상
- The University of Texas MD Anderson Cancer Center, Houston
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
피험자 모집 중2/3상
- Site#0102, Houston
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
피험자 모집 중2상
- The University of Texas MD Anderson Cancer Center, Houston
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
피험자 모집 중1상
- University of Texas MD Anderson Cancer Center, Houston
- The University of Texas, MD Anderson Cancer Center - West Houston, Houston
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
피험자 모집 중1상
- ALX Center 5, Houston
Pilot Study of Management of Facial Paralysis in the Oncologic Patient: Nerve Transfer Techniques to Improve Facial Function and Quality of Life
피험자 모집 중
- The University of Texas M. D. Anderson Cancer Center, Houston
Intratumoral N17350 in Advanced Solid Tumors
피험자 모집 중1/2상
- The University of Texas MD Anderson Cancer Center, Houston
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
피험자 모집 중1상
- MD Anderson Cancer Center, Houston
A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC
피험자 모집 중1상
- MD Anderson Cancer Center, Houston
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
피험자 모집 중1/2상
- The University of Texas, MD Anderson Cancer Center, Houston
IDOV-Immune for Advanced Solid Tumors
피험자 모집 중1상
- MD Anderson Cancer Center, Houston
Reversing External-beam Radiotherapy-associated Fibrosis Syndrome: an Interventional Bayesian Adaptive Randomized-controlled Orphan Drug Platform Trial for Orodental Sequelae (Reverse-fibrose)
피험자 모집 중2상
- MD Anderson Cancer Center, Houston
Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"
피험자 모집 중
- M D Anderson Cancer Center, Houston
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
피험자 모집 중1/2상
- University of Texas MD Anderson Cancer Center, Houston
Lead-212 PSV359 Therapy for Patients With Solid Tumors
피험자 모집 중1/2상
- MD Anderson Cancer Center, Houston
Implementing the NYU Electronic Patient Visit Assessment (ePVA) for Head and Neck Cancer In Rural and Urban Populations
피험자 모집 중
- UTHealth Houston Cizik School of Nursing, Houston
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
피험자 모집 중1/2상
- The University of Texas MD Anderson Cancer Center, Houston
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
피험자 모집 중1/2상
- MD Anderson Cancer Center, Houston
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
피험자 모집 중1/2상
- MD Anderson Cancer Center, Houston
Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Diagnosing Osteoradionecrosis in Patients With Head and Neck Cancer That Is Primary, Has Come Back, or Has Spread to Other Places in the Body
피험자 모집 중
- M D Anderson Cancer Center, Houston
Web-Based Program in Helping Patients With Head and Neck Cancer Adhere to Swallowing Exercises and Coping Strategies
피험자 모집 중2상
- M D Anderson Cancer Center, Houston
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
피험자 모집 중관찰 연구
- Md Anderson Cancer Center, Houston
Stereotactic MRI-guided Focused Ultrasound Mesencephalotomy
피험자 모집 중
- Baylor College of Medicine, Houston
Multi-Site Trial of Navigation vs Treatment as Usual to Improve Initiation of Timely Adjuvant Therapy
피험자 모집 중
- Baylor College of Medicine, Houston
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
피험자 모집 중1/2상
- The University of Texas MD Anderson Cancer Center (site 127), Houston
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
피험자 모집 중관찰 연구
- Massive Bio SYNERGY-AI site, Houston
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
피험자 모집 중1/2상
- MD Anderson Cancer Center, Houston
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
피험자 모집 중1상
- MD Anderson Cancer Center, Houston
Comprehensive Outcomes for After Cancer Health
피험자 모집 중건강한 지원자 환영
- The University of Texas MD Anderson Cancer Center, Houston
- UT Health Houston, Houston
다른 도시의 두경부암 시험
- Boston, MA연구 22개
- New York City, NY연구 21개
- Nashville, TN연구 21개
- St. Louis, MO연구 15개
- Dallas, TX연구 12개
- Pittsburgh, PA연구 11개
- Los Angeles, CA연구 10개
- San Antonio, TX연구 10개
- Baltimore, MD연구 10개
- Washington, DC연구 10개
- Durham, NC연구 10개
- Chicago, IL연구 10개
Houston의 다른 연구
- 비소세포폐암연구 145개
- 유방암연구 126개
- 암 (전체)연구 121개
- 전이성 암연구 104개
- 대장직장암연구 102개
- 난소암연구 89개
- 급성 골수성 백혈병연구 85개
- 폐암연구 78개
- 전립선암연구 76개
- 자궁내막암연구 68개
- 췌장암연구 61개
- 흑색종연구 59개
ClinicalTrials.gov 출처, 2026. 10. 6. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.